Introduction
============

Hospital-acquired *Clostridium difficile* infection, resulting in pseudomembranous colitis, is the most important cause of health care--associated diarrhea.[@JR1500076-1] [@JR1500076-2] Recent studies have shown that the incidence of *C. difficile* infection is rising, and it is becoming ever more challenging to treat because of emerging antibiotic-resistant strains.[@JR1500076-3] [@JR1500076-4] [@JR1500076-5] The pathophysiology of *C. difficile* infection is associated with alterations in the gut microflora, which can be triggered by antibiotic administration.[@JR1500076-6] [@JR1500076-7] Infection is characterized by constitutional symptoms, diarrhea and abdominal pain, and may lead to serious life-threatening complications such as toxic megacolon.[@JR1500076-8] Importantly, *C. difficile* is a highly contagious pathogen that can spread through a hospital especially in the setting of improper hand-washing practices and contact-precaution protocols.[@JR1500076-9] Consequently, proper perioperative administration of antibiotics, especially in high-risk patients, should be practiced to avoid this morbid and potentially fatal complication.

Postoperative *C. difficile* infection has been reported to increase length of stay (LOS), mortality, and costs.[@JR1500076-5] Maltenfort et al demonstrated that *C. difficile* infection after total knee arthroplasty increased LOS stay by a week, hospital charges by nearly U.S. \$40,000, and in-hospital mortality from 0.24 to 4.66%.[@JR1500076-10] Similarly, Skovrlj et al previously described a 36.4-fold increase in mortality in patients with *C. difficile* after lumbar spine surgery.[@JR1500076-11] Although an uncommon infection, it is clear that it has a significant impact.

Two key studies identified risk factors of *C. difficile* after orthopedic surgery. Campbell et al identified surgery \> 24 hours after admission, perioperative antibiotics, and proton pump inhibitors as risk factors for infection.[@JR1500076-12] Jenkins et al, in a similar study assessing *C. difficile* risk factors after total joint arthroplasty, identified additional postoperative antibiotic use as a significant factor for acquiring infection.[@JR1500076-13] However, these studies are limited by their relatively small sample size. Although there are studies examining *C. difficile* after lumbar spine surgery, there are currently no studies investigating the burden of *C. difficile* infection after cervical spine surgery. This study aims to identify incidence, prevalence, risk factors, and outcomes of *C. difficile* infection in a large sample of patients who underwent cervical spine surgery for degenerative causes.

Material and Methods
====================

The Nationwide Inpatient Sample (NIS) database, under the auspices of the Healthcare Cost and Utilization Project (HCUP), was queried from 2002 to 2011.[@OR1500076-14] The HCUP is a series of databases and related software tools developed through a federal--state--industry partnership, and it is the United States\' most comprehensive source of hospital data. One of the more robust databases of the HCUP, the NIS contains a 20% stratified sample numbering an estimated 1,000 hospitals throughout the United States, including ∼7 to 8 million hospital stays each year. Sample weights are created for each hospitalization based on the stratum the hospital belongs to (assigned by the American Hospital Association) by amassing the aggregate number of discharges in that stratum and dividing it by the total number of NIS discharges in that stratum.[@OR1500076-15] Appropriately applying these sample weights gives ∼40 million hospitalizations each year representing 96% of all U.S. hospital discharges. The NIS contains information on (but not limited to) hospital charges, procedures, diagnoses, and general patient characteristics. Institutional review board approval was not available for this study as the NIS contains no direct patient identifiers and is compliant with the Health Insurance Portability and Accountability Act of 1996 privacy rules.

Sample Selection
----------------

Hospitalizations with *C. difficile* diagnosis were identified by *International Classification of Diseases Ninth Revision, Clinical Modification* (ICD-9-CM) diagnosis code 008.45. Hospitalizations were selected for the study based on ICD-9-CM procedural codes for cervical spine procedures and diagnoses codes for degenerative conditions of cervical spine. The following procedural codes were included: anterior cervical fusion (81.02), posterior cervical fusion (81.03), refusion of cervical spine anterior technique (81.32), refusion of cervical spine posterior technique (81.33), posterior cervical decompression without fusion (03.09). Only hospitalizations of patients undergoing procedures for degenerative conditions including cervical spondylosis with and without myelopathy (721.1, 721.0), intervertebral disk (IVD) displacement with and without myelopathy (722.71, 722.0), IVD degeneration (722.4), postlaminectomy syndrome (722.81), calcification of IVD (722.91), other disorders of the cervical spine region including spinal stenosis (723.0--5), and ossification of the posterior longitudinal ligament (723.7) were selected.

Surgical Groups
---------------

Cervical spine procedures were further grouped to explore the risk of general procedure approach in the development of *C. difficile* infection. *Single-stage surgery* indicates anterior cervical fusion, posterior cervical fusion, or posterior decompression without fusion. *Circumferential fusion* includes those patients with concurrent anterior and posterior fusion during the hospitalization. *Primary fusion* included any cases of anterior or posterior fusion that were not coded as revision surgery. By contrast, *revision surgery* only included anterior or posterior fusion revisions.

Outcomes
--------

Patients were characterized as those with and without *C. difficile* diagnosis. We analyzed the prevalence of *C. difficile* infection by patient age, insurance type, gender, race and Elixhauser Comorbidity Index. The Elixhauser Index, similar to the Charlson Comorbidity Index, is a comorbidity risk adjustment model that aids in stratifying patients who are at higher risk for mortality.[@JR1500076-16] It includes updated diagnosis codes for comorbidities provided by the HCUP and adjusts for each single comorbidity\'s independent association with hospital death. It was chosen for its significant association with risk of mortality, especially beyond 30 days, as well as burden of disease.[@JR1500076-17] [@JR1500076-18] [@JR1500076-19] Moreover, charges were adjusted for inflation using the United States Bureau of Labor statistics yearly inflation calculator and are presented in 2011 U.S. dollars; charges were transformed into cost with the HCUP cost-to-charge ratio tool.[@OR1500076-20] [@OR1500076-21] The cost-to-charge tool allows us to assess not just what hospitals billed for services, but how much hospital services actually cost or specific amounts hospitals received in payment.

Data Analysis
-------------

The statistical analysis was performed using SAS version 9.3 (SAS Institute, Cary, North Carolina, United States). Chi-square test was used for analysis of categorical variables, and Student *t* test was used for continuous variables. The statistical significance of the time trend in the rate of hospitalizations with *C. difficile* infection was determined using the Cochran-Armitage trend test. We took into account clinically relevant variables such as previously published literature on this topic and multicollinearity and multivariable logistic regression for *C. difficile* diagnosis, and we controlled for relevant procedure types (circumferential fusion versus single stage surgery), age \> 65 years, sex, comorbidities (see [Appendix 1](#TB1500076-a1){ref-type="table"} for all included), hospital type (teaching versus nonteaching), location (urban versus rural), region (Northeast as reference), insurance type (uninsured versus insured), and common postoperative infections.[@JR1500076-10] [@JR1500076-11] The logistic regression model investigating risk factors associated with inpatient mortality after degenerative cervical spine surgery was also done. The statistical analysis took into account the stratified sampling design of the NIS database. Surveyfreq, surveymeans, and surveylogistic procedures were used for analysis. Discharge weights, NIS_stratum, and cluster (hospital identification) variables were included to correctly estimate variance and to produce national estimates. Statistical significance was maintained at *p* \< 0.05.

###### Factors included in multivariable analyses

  Dependent variable        Risk factors included
  ------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *Clostridium difficile*   Age \> 65 years, \*insurance (*insured versus uninsured*), race (*White as reference*), hospital region (*Northeast as reference*), hospital teaching status (*nonteaching reference*), hospital location (*urban versus rural*), hospital bed size (*large as reference*), comorbidities (perivascular disease, chronic hypertension, paralysis, neurological complications, pulmonary circulatory disorders, chronic lung disease, diabetes without complications, diabetes with chronic complications, renal failure, acquired immune deficiency syndrome, rheumatoid arthritis/collagen vascular disease, coagulation, obesity, fluid/electrolyte disorders, drug abuse, depression, circumferential surgery (*single stage surgery as reference*), pneumonia, urinary tract infection, postoperative infection not otherwise specified).
  Inpatient mortality       Diagnosis of *Clostridium difficile*, age \> 65 years, insurance *(insured versus uninsured)*, race *(White as reference)*, hospital region (*Northeast as reference)*, hospital teaching status *(nonteaching reference)*, hospital location *(urban versus rural)*, hospital bed size *(large as reference)*, comorbidities (perivascular disease, chronic hypertension, paralysis, neurological complications, pulmonary circulatory disorders, chronic lung disease, diabetes without complications, diabetes with chronic complications, renal failure, acquired immune deficiency syndrome, rheumatoid arthritis/collagen vascular disease, coagulation, obesity, fluid/electrolyte disorders, drug abuse, depression, circumferential surgery (*reference single stage surgery as reference*).

Insured patients (Private, Medicare, or Medicaid).

Results
=======

A total of 1,602,130 cervical spine surgeries were performed for degenerative conditions from 2002 to 2011. From this total, 1,270 hospitalizations were identified to have a concurrent *C. difficile* diagnosis. The incidence of *C. difficile* has been significantly increasing in the period queried ([Fig. 1](#FI1500076-1){ref-type="fig"}). A total of 3,044 (0.19%) patients without *C. difficile* infection died in the hospital after cervical spine surgery. Although only 101 patients with *C. difficile* infection died, this number accounted for 7.9% of all patients who acquired *C. difficile* infection after cervical spine surgery (*p* \< 0.0001).

![Trend of *Clostridium difficile* infection by year in degenerative cervical spine population from 2002 to 2011.](10-1055-s-0035-1562933-i1500076-1){#FI1500076-1}

Patients with *C. difficile* infection were more likely to be male (*p* \< 0.0015) and more likely to be over the age of 65, with a mean age of 66.8 years versus 53.4 years in those without *C. difficile* (*p* \< 0.0001; [Table 1](#TB1500076-1){ref-type="table"}). Patients with *C. difficile* infection were also more likely to have undergone posterior cervical fusion and circumferential fusion when compared with those without postoperative *C. difficile* infection ([Table 1](#TB1500076-1){ref-type="table"}).

###### Demographic information of patients with and without *Clostridium difficile* infection after degenerative cervical spine surgery

  Population                                          *C. difficile* (1,270)   No *C. difficile* (1,600,860)   *p* Value
  --------------------------------------------------- ------------------------ ------------------------------- -----------
  Sex (%)                                                                                                      0.002
   Male                                               59.2                     49.6                            
   Female                                             40.8                     50.4                            
  Mean age                                            66.8                     53.4                            \<0.0001
  Age groups, y (%)                                                                                            \<0.0001
   0--44                                              6.1                      24.7                            
   45--65                                             34.3                     55.7                            
   \> 65                                              59.6                     19.6                            
  Race (%)                                                                                                     \<0.0001
   White                                              60.9                     62.4                            
   Black                                              11.2                     7.2                             
   Hispanic                                           7.4                      3.8                             
   Asian or Pacific                                   3.1                      0.9                             
   Native American                                    0.4                      0.3                             
   Other                                              2.3                      1.7                             
   Missing race                                       14.7                     23.6                            
  Insurance (%)                                                                                                \<0.0001
   Medicare                                           63.8                     24.5                            
   Medicaid                                           11.5                     8.6                             
   Private                                            19.9                     55.5                            
   Uninsured                                          1.6                      1.7                             
   Other                                              2.7                      9.4                             
  Elixhauser Comorbidity Index                        7.6                      0.5                             \<0.0001
  Hospital size (%)                                                                                            0.001
   Small                                              5.5                      11.6                            
   Medium                                             17.7                     21.9                            
   Large                                              76.8                     66.5                            
  Hospital location (%)                                                                                        0.073
   Rural                                              1.9                      4.8                             
   Urban                                              98.1                     95.2                            
  Hospital teaching status (%)                                                                                 0.001
   Nonteaching                                        34.7                     46.6                            
   Teaching                                           65.3                     53.4                            
  Procedures (*n*, Rate %)                                                                                     
   Anterior cervical fusion                           467 (36.8)               1,225,346 (76.54)               \<0.0001
   Posterior cervical fusion                          258 (20.3)               88,766 (5.5)                    \<0.0001
   Fusion revision anterior approach                  20 (1.6)                 27,172 (1.7)                    0.919
   Fusion revision posterior approach                 19 (1.5)                 13,362 (0.8)                    0.235
   Circumferential fusion                             150 (11.8)               28,534 (1.8)                    \<0.0001
   Posterior cervical decompression without fusion    356 (28.0)               217,680 (13.6)                  \<0.0001
   All cervical surgeries                             1,270 (0.08)             1,600,860                       --
  Mortality total cases, *n* (% population)           101 (7.9%)               3,044 (0.19%)                   \<0.0001
  Common postoperative complications                                                                           
   Pneumonia                                          137 (10.8%)              2,342 (0.15%)                   \<0.0001
   Urinary tract infection                            355 (27.96%)             22,197 (1.38%)                  \<0.0001
   Postoperative infection, not otherwise specified   58(4.6%)                 2,252 (0.14%)                   \<0.0001

In multivariable logistic regression modeling for postoperative *C. difficile* infection, age \> 65 was identified to be a significant risk factor for acquiring infection (odds ratio \[OR\] = 2.63, 95% confidence interval \[CI\] = 1.86 to 3.73, *p* \< 0.0001). Congestive heart failure, peripheral vascular disease, paralysis, chronic lung disease, renal failure, coagulation, and fluid/electrolyte disorders were all significant predictors of postoperative *C. difficile* infection ([Table 2](#TB1500076-2){ref-type="table"}). A diagnosis of pneumonia, postoperative infection not otherwise specified, and urinary tract infections were also significantly associated postoperative *C. difficile* colitis. Circumferential fusion when referenced to single-stage surgery also increased the odds of postoperative infection (OR = 2.93, 95% CI = 1.75 to 4.90, *p* \< 0.0001).

###### Independent risk factors increasing the odds of *Clostridium difficile* after cervical spine surgery

  Risk factor                   Odds ratio   Low 95% CI   High 95% CI   *p* Value
  ----------------------------- ------------ ------------ ------------- -----------
  Age \> 65 y                   2.63         1.86         3.73          \<0.0001
  Hispanic                      1.52         0.93         2.49          \<0.0001
  Asian                         2.00         0.91         4.39          \<0.0001
  Other race                    1.41         0.60         3.29          \<0.0001
  Congestive heart failure      2.79         1.82         4.28          \<0.0001
  Perivascular disease          2.32         1.27         4.21          0.006
  Paralysis                     2.27         1.48         3.50          0.0002
  Chronic lung disease          1.58         1.12         2.23          0.0097
  Renal failure                 2.04         1.26         3.30          0.0039
  Coagulation                   2.31         1.25         4.27          0.0075
  Fluid/electrolyte disorders   6.54         4.49         9.52          \<0.0001
  Circumferential surgery       2.93         1.75         4.90          \<0.0001
  Pneumonia                     5.80         3.33         10.10         \<0.0001
  Postoperative infection       6.95         3.08         15.67         \<0.0001
  Urinary tract infection       5.12         3.28         8.00          \<0.0001

Abbreviation: CI, confidence interval.

Multivariate regression analysis in patients undergoing degenerative cervical spine surgery identified *C. difficile* infection as a significant risk factor for inpatient mortality (OR = 3.99, 95% CI = 2.15 to 7.38, *p* \< 0.0001; [Table 3](#TB1500076-3){ref-type="table"}). In addition to increasing the odds of infection, circumferential fusion was also significantly associated with increased overall inpatient mortality in this population (OR = 2.74, 95% CI = 1.92 to 3.91, *p* \< 0.0001).

###### Independent risk factors increasing the odds of inpatient mortality after cervical spine surgery

  Risk factor                       Odds ratio   Low 95% CI   High 95% CI   *p* Value
  --------------------------------- ------------ ------------ ------------- -----------
  *Clostridium difficile*           3.99         2.15         7.38          \<0.0001
  Age \> 65 y                       3.82         3.05         4.8           \<0.0001
  Teaching hospital                 1.29         1.05         1.59          0.016
  Congestive heart failure          3.81         2.8          5.18          \<0.0001
  Paralysis                         5.12         4.02         6.52          \<0.0001
  Neurologic complications          1.8          1.29         2.52          0.001
  Pulmonary circulatory disorders   6.47         4.06         10.32         \<0.0001
  Renal failure                     2.33         1.64         3.29          \<0.0001
  Acquired immune deficiency        3.33         1.1          10.07         0.033
  Coagulation                       3.93         2.8          5.51          \<0.0001
  Fluid/electrolyte disorder        5.27         4.15         6.68          \<0.0001
  Circumferential surgery           2.74         1.92         3.91          \<0.0001

Abbreviation: CI, confidence interval.

Discussion
==========

This study demonstrates that *C. difficile* infection after cervical spine surgery for degenerative pathology is a rare, yet morbid and fatal postoperative complication. The rate of *C. difficile* infection significantly increased after cervical spine surgery from 2002 to 2011, and overall prevalence was 0.08%. There are multiple reasons for this observation, from better reporting to improved diagnostic techniques. There is growing evidence that postoperative *C. difficile* incidence may be increasing due to evolving antibiotic-resistant strains, such as the hypervirulent strain NAP1/BI/027.[@JR1500076-6] [@JR1500076-22] Our study indicates that *C. difficile* is a significant independent risk factor associated with inpatient mortality in patients after cervical spine surgery.

The increased risk of *C. difficile* infection after degenerative cervical spine surgery in patients with certain comorbidities such as advanced chronic kidney disease (CKD) that cause impaired immunity is well recognized in the literature.[@JR1500076-23] [@JR1500076-24] Patients with CKD have dysfunctional gastric acid secretion and are susceptible to infections that may require antibiotics, thus making this patient population particularly vulnerable.[@JR1500076-24] [@JR1500076-25] There is a similar, although distinct, risk seen in those patients who have been on prolonged treatment with proton pump inhibitors prior to surgery.[@JR1500076-12] [@JR1500076-26] Patients in this population with postoperative infection like pneumonia have understandably higher odds for postoperative *C. difficile* colitis, presumably due to the use of antibiotics to treat such infections. However, not all cases of *C. difficile* in this population had these common infections and thus there may have been some cases in which the administration of antibiotics was suboptimal.

The increased rate of *C. difficile* in patients with Medicare versus private insurance may be due to an age effect that cannot be completely explained by the NIS. However, because most patients eligible for Medicare are, at minimum, 65 years of age or with a severe medical comorbidity, it is possible that the Medicare beneficiaries are slightly sicker and at an increased risk of infection.[@OR1500076-27] Indirectly supporting this age effect is the fact that in multivariate analysis for *C. difficile* infection, age \> 65 was a significant independent variable for the risk of infection.

Although the NIS has limitations with respect to detailed surgical techniques, such as explicit procedure (e.g., anterior corpectomy and fusion), our study shows the effect different general procedures had on *C. difficile* incidence and overall inpatient mortality. Posterior approaches had a higher incidence of *C. difficile* when compared with anterior approaches, likely because the anterior approach is relatively muscle-sparing and the posterior approach is muscle-splitting and may be associated with longer LOS, which may lead some surgeons to expose these patients to prolonged antibiotic administration. In multivariate analyses for postoperative *C. difficile* diagnosis and inpatient mortality, circumferential fusion was associated with increased likelihood of postoperative *C. difficile* colitis and increased risk for in-hospital death. Increased incidence of *C. difficile* infection and general inpatient mortality in these cases may be due to the invasive nature of the combined approach, leading to longer operating times, increased perioperative antibiotic administration, and a more difficult postoperative course.

Despite no antibiotic data available in the NIS, there are some important considerations that should be addressed. Because the development of *C. difficile* infection is not necessarily dependent on the type of procedure but rather antibiotic administration, it is critical that spine surgeons follow the hospital-instituted antibiotic guidelines to avoid potential complications. The use of any antibiotics, but more commonly clindamycin, cephalosporins (second-generation or higher), fluoroquinolones, and multiple regimens, is believed to modify the normal gut microflora, predisposing to *C. difficile* colitis.[@JR1500076-4] [@JR1500076-22] [@JR1500076-28] Currently, The Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery, developed in a collaborative effort by the American Society of Health Care Pharmacist, recommends a single dose of cefazolin or any other first-generation cephalosporin 1 hour prior to surgical incision, as antibiotic prophylaxis for orthopedic spine surgeries with or without instrumention.[@JR1500076-29] These same guidelines indicate that clindamycin or vancomycin may be used in those patients who have a β-lactam allergy.

These evidence-based guidelines and others, such as the Surgical Care Improvement Project, are not universally followed, and clinical experience shows that spine surgeons may utilize modified antibiotic practices that can lead to rare but potentially deadly infections such as *C. difficile* colitis.

The economic impact of *C. difficile* must also not be overlooked. Cervical spine patients with *C. difficile* infection cost approximately \$6,830,695 per year to manage as calculated by median costs and total number of patients with infection averaged over our study period ([Table 4](#TB1500076-4){ref-type="table"}), which is a significant impact on health resources despite being a rare occurrence.

###### Costs and length of stay in patients with or without *Clostridium difficile* after degenerative cervical spine surgery

                                                                 Hospital costs (U.S. \$)             Length of stay (d)                  
  -------------------------------------------------------------- -------------------------- --------- -------------------- ------ ------- ----------
  Fusion revision[a](#FN1500076-4){ref-type="table-fn"}                                                                                   
  Mean                                                           19,542                     100,676   \<0.0001             3.25   22.81   \<0.0001
  Median                                                         14,777                     88,006    \<0.0001             1.55   17.82   \<0.0001
  Q1                                                             10,403                     48,199                         0.69   5.72    
  Q3                                                             22,709                     110,284                        2.95   32.53   
  Circumferential fusion[b](#FN1500076-5){ref-type="table-fn"}                                                                            
  Mean                                                           40,865                     71,002    \<0.0001             7.06   24.98   \<0.0001
  Median                                                         34,510                     66,805    \<0.0001             4.16   19.09   \<0.0001
  Q1                                                             24,085                     31,765                         2.49   7.62    
  Q3                                                             49,849                     78,973                         7.38   28.64   
  Single-stage surgery[c](#FN1500076-6){ref-type="table-fn"}                                                                              
  Mean                                                           13,892                     64,431    \<0.0001             2.37   25.2    \<0.0001
  Median                                                         11,342                     48,045    \<0.0001             0.88   19.39   \<0.0001
  Q1                                                             8,309                      30,077                         0.43   11.29   
  Q3                                                             16,036                     79,298                         1.9    30.82   
  All cervical surgeries                                                                                                                  
  Mean                                                           14,520                     66,237    \<0.0001             2.48   25.1    \<0.0001
  Median                                                         11,530                     53,785    \<0.0001             0.91   19.15   \<0.0001
  Q1                                                             8,399                      30,321                         0.44   10.9    
  Q3                                                             16,550                     81,868                         1.97   31.07   

Anterior fusion revision or posterior fusion revision.

Concurrent anterior and posterior fusion.

Anterior fusion, posterior fusion, or posterior decompression without fusion.

Limitations
-----------

Several important conclusions cannot be made due to limitations when using the NIS. One such limitation is the absence of data on antibiotic administration. Because weakening the resistance and altering the normal intestinal microbiota by antibiotics remains the single most important risk factor for colonization and susceptibility to infection, important observations about dosage, duration, and high-risk antibiotics would have been of vital importance.[@JR1500076-30] The identified risk factors such as increased incidence of postoperative infections, certain comorbidities such as CKD, or complex two-step procedures such as circumferential surgery may be surrogates for the use of multiple or more broad-spectrum antibiotics rather than being the primary risk factors.

Despite relatively reliable medical tests to diagnose *C. difficile* infection, the method of diagnosis is not available when using the NIS.[@JR1500076-4] Errors in *C. difficile* diagnosis may stem from prophylactically identifying patients experiencing an active infection at the first sign of postoperative diarrhea. Although these patients may indeed have *C. difficile* infection, the diagnosis cannot be confirmed until proper laboratory tests are performed, which may lead to an overestimation of *C. difficile* incidence. However, these same conclusions may lead to an underestimation because some patients with postoperative diarrhea may be falsely classified as not having an active infection.

Conclusion
==========

With the use of the NIS, we were able to accurately investigate the national trend of *C. difficile* infection after elective cervical spine surgery for degenerative causes. Postoperative *C. difficile* infection in this population results in extended hospital stay, greater costs, and increased inpatient mortality. Although being a rare infection after cervical spine surgery, it is significantly increasing in incidence likely due to novel antibiotic-resistant strains and improper antibiotic use. Due to the fatal impact this infection carries, proper pre- and postoperative antibiotic stewardship should be practiced in this population especially in patients \> 65 years of age and with high-risk comorbidities such as diabetes with chronic complications and CKD.
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